1268245-50-6 Usage
Description
4-(chloromethyl)-5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazole is a heterocyclic compound characterized by its unique molecular structure featuring a 1,2-oxazole ring fused with a dichlorophenyl group and a cyclopropyl moiety. 4-(chloromethyl)-5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazole is known for its potential applications in the pharmaceutical industry, particularly as an intermediate in the synthesis of various drugs.
Uses
Used in Pharmaceutical Industry:
4-(chloromethyl)-5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazole is used as a pharmaceutical intermediate for the development of new drugs. Its unique chemical structure allows it to serve as a building block in the synthesis of various medicinal compounds, potentially leading to the creation of novel therapeutic agents.
Used in Pharmaceutical Experimental Research:
In addition to its role as a pharmaceutical intermediate, 4-(chloromethyl)-5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazole is also utilized in experimental research. Researchers can leverage its properties to investigate its potential interactions with biological targets, such as receptors or enzymes, which may provide insights into the development of new treatments for various diseases and conditions.
storage
4-(chloromethyl)-5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazole can store at Room Tem.
Check Digit Verification of cas no
The CAS Registry Mumber 1268245-50-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,6,8,2,4 and 5 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1268245-50:
(9*1)+(8*2)+(7*6)+(6*8)+(5*2)+(4*4)+(3*5)+(2*5)+(1*0)=166
166 % 10 = 6
So 1268245-50-6 is a valid CAS Registry Number.
1268245-50-6Relevant articles and documents
HORMONE RECEPTOR MODULATORS FOR TREATING METABOLIC CONDITIONS AND DISORDERS
-
, (2018/03/25)
The invention relates to activators of FXR useful in the treatment of autoimmune disorders, liver disease, intestinal disease, kidney disease, cancer, and other diseases in which FXR plays a role, having the Formula (I): (I), wherein L1, A, X1, X2, R1, R2, and R3 are described herein.
ISOXAZOLYL-CARBONYLOXY AZABICYCLO[3.2.1]OCTANYL COMPOUNDS AS FXR ACTIVATORS
-
, (2018/09/25)
The disclosure relates to activators of FXR useful in the treatment of autoimmune disorders, liver disease, intestinal disease, kidney disease, cancer, and other diseases in which FXR plays a role, having the Formula (I): wherein L1, L2, A, B, R1, R2, R3, and R4 are described herein.
FXR (NR1H4) MODULATING COMPOUNDS
-
Paragraph 0223; 0225, (2018/01/19)
The present disclosure relates generally to compounds which bind to the NR1H4 receptor (FXR) and act as agonists of FXR. The disclosure further relates to the use of the compounds for the preparation of a medicament for the treatment of diseases and/or co
